Canagliflozin as a replacement therapy for patients with type 2 diabetes not responding to GLP-1 receptor agonists

2017 
Diabetes & Metabolism - In Press.Proof corrected by the author Available online since mercredi 3 mai 2017
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []